Search alternatives:
significantly longer » significantly lower (Expand Search), significantly larger (Expand Search), significantly higher (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
longer decrease » larger decrease (Expand Search), linear decrease (Expand Search), largest decrease (Expand Search)
significantly longer » significantly lower (Expand Search), significantly larger (Expand Search), significantly higher (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
longer decrease » larger decrease (Expand Search), linear decrease (Expand Search), largest decrease (Expand Search)
-
3561
-
3562
Line graph showing the values of inflammatory cytokines at baseline and after treatment.
Published 2025Subjects: -
3563
Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness.
Published 2024Subjects: -
3564
-
3565
-
3566
-
3567
-
3568
Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups.
Published 2024Subjects: -
3569
-
3570
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: -
3571
-
3572
-
3573
-
3574
Baseline descriptive characteristics of trial participants with dizziness, by treatment group.
Published 2024Subjects: -
3575
-
3576
Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.
Published 2025Subjects: -
3577
Relative abundance of microbiota in colonic content at the genus level (n = 5).
Published 2025Subjects: -
3578
-
3579
Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.
Published 2025Subjects: -
3580
Variables obtained from the SF-36 quality of life questionnaire in each experimental group.
Published 2025Subjects: